Kankakee


CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative therapies. The company offers the broadest range of products in the industry for treating coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. CSL Behring’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.


Information

Corporate Responsibility Report

Contact
CSL Behring Kankakee
1201 N. Kinzie Avenue
Bradley, IL 60915
Telephone: 815-932-6771

The company operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL), headquartered in Melbourne, Australia, employs nearly 20,000 people, providing life-saving therapies to people in more than 60 countries.

Throughout our 65-year history, the Kankakee site has been successful because of the service of our outstanding workforce who is passionately committed to providing high-quality therapies to patients who rely on them.
CSL Behring in Kankakee
Core products: Albumin, Intermediate Pastes

Specialty Products: Coagulation Factors, Alpha 1-Proteinase Inhibitor

Over 1,400 employees
Features
News